Liaoning Oxiranchem Inc

Liaoning Oxiranchem Inc has a market capitalization of 7.26 billion CNY and a price-to-earnings ratio of 1067.59, indicating a high valuation relative to earnings. The company's price-to-book ratio of 2.65 suggests that the market values the company at a premium to its book value. The enterprise value to EBITDA ratio of 699.70 is extremely high, reflecting either strong investor expectations or weak earnings performance. The company's profitability metrics are weak, with a return on equity of 0.25% and a return on assets of 0.12%. These figures are significantly below the typical performance of companies in the specialty chemicals industry, which usually exhibit higher returns due to the premium nature of their products. The operating margin is 3.25%, and the net profit margin is 1.61%, both of which are low for a company in this sector. Liaoning Oxiranchem Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's financial statements do not provide segment-specific revenue data, making it difficult to assess the contribution of different product lines or geographic regions to overall performance. This lack of diversification increases the company's exposure to sector-specific risks. The company's growth trajectory is uncertain, with no disclosed revenue growth rates or future projections. The operating cash flow is negative at -465.88 million CNY, while the free cash flow is positive at 132.54 million CNY. The capital expenditure of -20.64 million CNY indicates minimal investment in new projects or capacity expansion. Analysts have assigned a mean recommendation of 1.00, indicating a strong buy, but the company's recent earnings performance has been weak, with a last actual EPS of 0.01 CNY compared to a mean estimate of 0.06 CNY. The company faces moderate liquidity risk, with a current ratio of 0.92, indicating that it has less current assets than current liabilities. The debt-to-equity ratio of 0.85 suggests a moderate level of leverage, but the negative net cash position after subtracting total debt raises concerns about the company's ability to meet short-term obligations. The risk assessment indicates a low probability of dilution, but the company's weak profitability and high valuation multiples suggest that it may need to raise additional capital in the future. Recent events and filings do not provide specific details about the company's strategic initiatives or operational changes. The company's financial performance has been weak, with a net income of 6.80 million CNY and an operating income of 13.72 million CNY. The company's long-term debt of 2.34 billion CNY is a significant portion of its total liabilities, and the lack of disclosed capital raising activities suggests that the company is not actively addressing its debt burden.